Haryana FDA Alert: Contaminated Cough Syrup Batch Found
Haryana's FDA issues an alert after Almont-Kid cough syrup batch is found with toxic ethylene glycol above limits. Consumers urged to check batch number AL-24002 immediately.
Haryana's FDA issues an alert after Almont-Kid cough syrup batch is found with toxic ethylene glycol above limits. Consumers urged to check batch number AL-24002 immediately.
Lords Mark Industries Ltd. hits a major milestone with 153 products listed by the US FDA, boosting India's medtech export potential and global healthcare standards.
A new BMJ study reveals alarming weight regain after stopping drugs like Ozempic. Experts warn against treating them as short-term trends. Learn the facts and risks.
In a NYT interview, Donald Trump revealed he hasn't used GLP-1 drugs like Ozempic, sparking debate on obesity, healthcare costs, and his administration's drug price policies. Read the full story.
Discover how Mumbai's 179-year-old Khojati surma, born from a prophecy, uses FDA-approved formulas & global reach to revive a dying art for a new generation. #IndianHeritage #Beauty
At CES 2024, AI health gadgets like smart scales & hormone trackers promised to fill healthcare gaps. Experts warn of accuracy, bias & data privacy risks as US relaxes regulations. Read more.
Maharashtra FDA officials confiscated raw tobacco and hookah products worth Rs 31.67 crore from a Pune unit. This major crackdown follows a similar raid in Thane, enforcing a strict ban on such hazardous substances.
Novo Nordisk launches oral Wegovy weight-loss drug in the US, priced at $299. The pill, approved in Dec 2025, aims to regain market share from rival Eli Lilly. UK approval expected end-2026.
The US FDA has approved Mitapivat (Aqvesme), the first oral treatment for anemia in adults with alpha or beta thalassemia. This breakthrough could reduce transfusion dependence, offering new hope for high-burden countries like India. Read more.
Novo Nordisk expects India's obesity drug market to grow rapidly after a 37% Wegovy price cut, mirroring insulin uptake. Generic competition looms with a Rs 5000-crore opportunity.
US FDA approves Mitapivat, the first oral therapy for thalassemia anemia. Indian hematologists welcome the breakthrough but highlight access and affordability challenges in India. Read more.
The US FDA has approved mitapivat (Aqvesme), the first oral drug treating anaemia in thalassaemia at a cellular level. Indian specialists explain its transformative potential for patients, especially in high-burden India.
Lucknow Development Authority launches FastPass for instant online building plan approval via self-certification, cutting process from months to minutes. Learn how it works.
Wall Street's major indexes fell slightly on the last trading day of 2025 but are set for strong double-digit yearly gains, fueled by AI stocks. Nike and Vanda Pharma saw notable moves.
As GLP-1 drugs like Ozempic launched in India, experts warn they are not a magic fix. Sustainable metabolic health requires diet, exercise, and stress management. Learn why.
CDC and FDA investigations reveal Salmonella, E. coli in some moringa leaf powders. Learn about the health risks, outbreak details, and how to stay safe.
New research reveals GLP-1 weight-loss drugs like Ozempic significantly cut grocery and restaurant spending. Discover the impact on food habits in India and globally.
Pune Rural police arrest a 34-year-old for impersonating an FDA official and demanding a bribe from a Rajgurunagar pharmacist. The accused was caught with a fake ID card. Read the full details.
Maharashtra FDA launches a 21-day intensive inspection campaign targeting hotels and restaurants from Dec 26 to Jan 15 to ensure safe, unadulterated food during New Year celebrations. Minister Narhari Zirwal directs thorough checks.
Over 80,000 bags of shrimp recalled in the US due to potential cesium-137 contamination. Check brands, states affected, and health risks. Do not consume and return product.
A new Gallup poll reveals Fed Chair Jerome Powell is more popular than President Trump. Discover the key figures and the story behind this political clash. Read more!
Donald Trump's latest Gallup poll approval rating stands at a mere 37%, the lowest for any modern president in a second term. Dive into the details and analysis of this political setback.
US FDA approves Novo Nordisk's daily Wegovy pill, an oral alternative to injections. Priced from $149, it offers 14% average weight loss. Details on cost, side effects, and how it compares to rivals.
Shares of Novo Nordisk surged over 7% after its weight loss drug Wegovy pill received US FDA approval on December 22, 2025. Read the full market impact analysis.
FDA research reveals most drugs last years beyond expiry if stored properly. Learn which pills are safe and which to discard immediately. Consult your pharmacist.
US FDA approves Novo Nordisk's Wegovy Pill, first oral GLP-1 drug for weight loss. Priced at $149/month, it promises wider access and challenges injectable dominance. Read more.
The US FDA approves Jascayd tablets for adults with progressive pulmonary fibrosis (PPF), expanding treatment options. Learn about the drug's impact, study results, and what it means for patients.
Chhattisgarh's FDA launches a major drive against food adulteration, seizing contaminated paneer and sweets. Details on raids, destroyed stock, and mobile testing labs inside.
Women share harrowing experiences of stopping anti-obesity drugs like Wegovy. Experts warn 60-80% weight returns without a plan. Learn about the side effects and new drugs in India.
A new topical cream, Vylessi, using a Viagra-like drug, is launched in the US to treat female sexual arousal disorder. Learn about its mechanism and availability.